You are here: Industry Insights > Adagene

News List

Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore prnasia
October 28, 2021
Adagene Inc. ("Adagene") (Nasdaq: ADAG), the National University Cancer Institute, Singapore (NCIS) at the National University Hospital in Singapore, National Cancer Centre Singapore (NCCS)...
Adagene Achieves CAR-T Collaboration Milestone contractpharma
January 13, 2021
Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.
ADC Therapeutics, Adagene Ink License Agreement contractpharma
April 26, 2019
ADC Therapeutics, an oncology drug discovery and development company that specializes in antibody drug conjugates (ADCs), and Adagene Inc., an antibody engineering and discovery company ...
Adagene to evaluate dynamic precision library platform with Celgene biospectrumasia
March 04, 2019
Adagene will use its Dynamic Precision Library, to discover antibodies against targets chosen by Celgene
Adagene collaborates with NIH to discover novel CAR-T biospectrumasia
January 07, 2019
Adagene, Inc., an innovative antibody discovery and engineering company, announced collaboration with Dr. Richard Childs, Chief of the Laboratory of Transplantation Immunotherapy at the National...
Adagene Raises $50 Million in Series C Funding prnasia
March 28, 2018
Leading antibody discovery and development company Adagene Inc. today announced US$50 million Series C financing led by Sequoia China
Adagene Raises $50 Million in Series C Funding biospace
March 28, 2018
Leading antibody discovery and development company Adagene Inc. today announced US$50 million Series C financing led by Sequoia China
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership prnasia
March 12, 2018
WuXi Biologics (2269.HK) and Adagene Inc.,today announced a strategic collaboration agreement.